FindTrial
Sign In

A multi-center randomized controlled trial for transurethral thulium laser enucleation of prostate and bladder neck incision versus thulium laser vaporization resection in small prostates

A multi-center randomized controlled trial for transurethral thulium laser enucleation of prostate and bladder neck incision versus thulium laser vaporization resection in small prostates

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048816
Enrollment
Unknown
Registered
2021-07-17
Start date
2020-01-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Experimental Group:Thulium laser enucleation of prostate+ incision of bladder neck
Control Group:Thulium laser vaporization resection

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. BPH patients aged 50-85 years; 2. Prostate volume = 8 points; 5. Qmax < 15ml/s.

Exclusion criteria

Exclusion criteria: 1. Neurogenic disease; 2. Acute urinary tract infections and not effectively controlled; 3. Factors of lower urinary tract obstruction except BOO (such as urethral stricture,urethral tumour); 4. History of radiotherapy or operation in lower urinary tract or pelvis; 5. Bladder tumor,prostatic cancer.

Design outcomes

Primary

MeasureTime frame
Complications;—

Secondary

MeasureTime frame
IPSS;QoL;IIEF-5;urinalysis;blood analysis;—

Countries

China

Contacts

Public ContactYifeng Jing

Shanghai General Hospital

jyf_123@163.com+86 13918839913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026